These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1801634)

  • 1. Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients.
    Cryz SJ; Fürer E; Que JU; Sadoff JC; Brenner M; Schaad UB
    Antibiot Chemother (1971); 1991; 44():157-62. PubMed ID: 1801634
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM; Losowsky MS
    J Clin Pathol; 1986 Oct; 39(10):1124-9. PubMed ID: 3097080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
    Pier GB
    J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis.
    Thanasekaraan V; Wiseman MS; Rayner RJ; Hiller EJ; Shale DJ
    Arch Dis Child; 1989 Nov; 64(11):1599-603. PubMed ID: 2513779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal administration of a Pseudomonas lipopolysaccharide vaccine in cystic fibrosis patients.
    Wood RE; Pennington JE; Reynolds HY
    Pediatr Infect Dis; 1983; 2(5):367-9. PubMed ID: 6415621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
    J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
    Hancock RE; Mouat EC; Speert DP
    J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
    Neter E
    J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
    [No Abstract]   [Full Text] [Related]  

  • 17. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB; Lang AB; Wedgwood J; Ruedeberg A; Que JU; Fürer E; Cryz SJ
    Lancet; 1991 Nov; 338(8777):1236-7. PubMed ID: 1682645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.
    Speert DP
    Surv Synth Pathol Res; 1985; 4(1):14-33. PubMed ID: 3927464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.